Efficiency ratio and rocketing drug prices: old concerns and new possibilities Stefano CapriFernando Antonanzas Editorial 05 May 2020 Pages: 1273 - 1277
The impact of the diabetes management incentive on diabetes-related services: evidence from Ontario, Canada Thaksha ThavamRose Anne DevlinSisira Sarma Original Paper 16 July 2020 Pages: 1279 - 1293
General practitioners’ income and activity: the impact of multi-professional group practice in France Matthieu CassouJulien MousquèsCarine Franc Original Paper 14 October 2020 Pages: 1295 - 1315
Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome Laura PirhonenHanna GyllenstenKristian Bolin Original Paper Open access 07 September 2020 Pages: 1317 - 1327
Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature Klas KellerborgWerner BrouwerPieter van Baal Original Paper Open access 13 August 2020 Pages: 1329 - 1350
Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany Edin BasicMathias KappelDennis A. Ostwald Original Paper Open access 11 July 2020 Pages: 1351 - 1361
Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas Richard Huan XuEliza Lai Yi WongDong Dong Original Paper 22 September 2020 Pages: 1363 - 1373
No gain in pain: psychological well-being, participation, and wages in the BHPS Elena LagomarsinoAlessandro Spiganti Original Paper Open access 22 September 2020 Pages: 1375 - 1389
How French general practitioners respond to declining medical density: a study on prescription practices, with an insight into opioids use Julien SilholBruno VentelouAnna Zaytseva Original Paper 03 August 2020 Pages: 1391 - 1398
Timing matters: worker absenteeism in a weekly backward rotating shift model Bernd FrickRobert SimmonsFriedrich Stein Original Paper 15 September 2020 Pages: 1399 - 1410
Multiplicative modelling of EQ-5D-3L TTO and VAS values Asrul Akmal ShafieAnnushiah Vasan Thakumar Original Paper 05 September 2020 Pages: 1411 - 1420
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies Doug CoyleIsabelle Durand-ZaleskiKoonal Shah Original Paper 13 August 2020 Pages: 1421 - 1437
